期刊文献+

甲基化修饰对IgA肾病外周血B淋巴细胞Cosmc基因表达的调节作用 被引量:5

Effect of Methylation Modification on the Expression of Cosmc Gene in Peripheral B Lymphocyte of IgA Nephropathy Patients
原文传递
导出
摘要 目的探讨甲基化修饰对IgA肾病患者外周血B淋巴细胞Cosmc基因mRNA表达水平的影响。方法用抗凝管采集22例IgA肾病患者和20例健康体检者(正常对照)静脉血,采用磁珠分离外周血B淋巴细胞,以RPMI1640、脂多糖(LPS 12.5μg/mL)和5-氮杂胞苷(5-AZA 0.1、0.5和1.0μmol/L)处理72h。采用实时荧光RT-PCR的方法测定Cosmc表达水平。结果 IgA肾病患者外周血B淋巴细胞Cosmc基因mRNA表达水平低于正常对照(31.3%,P<0.05)。经RPMI1640培养基处理后IgA肾病患者Cosmc基因的表达升高(为处理前的219%,P<0.05),但LPS能逆转Cosmc基因的表达上调(降低至RPMI1640组的60%)。采用5-AZA进行去甲基化修饰后Cosmc基因表达上调(5-AZA 0.1、0.5、1.0μmol/L处理后Cosmc基因表达上升至RPMI1640组的67%、82%和103%)。结论以LPS为代表的外源性抑制介质通过甲基化修饰抑制了Cosmc基因的表达,而去甲基化修饰则能有效的逆转Cosmc基因受抑情况。5-AZA可能具有治疗IgA肾病的潜力。 Objective To investigate the effect of methylation modification on the mRNA expression of Cosmc gene in peripheral B lymphocytes from IgA nephropathy(IgAN).Methods Biopsy identified 22 cases of IgAN patients and 20 cases of normal control were included.Peripheral B lymphocytes were isolated and were cultured with RPMI1640 medium,with LPS(12.5 μg/mL) as well as demethylation agent(5-AZA 0.1 μmol/L,0.5 μmol/L and 1.0 μmol/L) for 72 hours,respectively.Expression level of Cosmc gene was measured using real-time PCR.Results The mRNA expression level of Cosmc gene in IgAN patients was significantly lower than that of control(P0.05).The Cosmc gene expression level increased dramatically after RPMI1640 treatment(P0.05),however,LPS could apparently reverse this effect(P0.05).De-methylation modification up regulated the Cosmc gene expression significantly(P0.05).Conclusion De-methylation modification could effectively reverse the repressed Comsc gene mRNA expression caused by external suppressors.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2011年第6期762-765,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(批准号30800527)资助
关键词 IGA肾病 Cosmc基因 去甲基化修饰 IgA nephropathy Cosmc gene De-methylation modification
  • 相关文献

参考文献2

二级参考文献25

  • 1邱强,白雪源,陈香美.IgA肾病患者核心1β3-半乳糖基转移酶基因编码区序列分析[J].军医进修学院学报,2005,26(4):288-289. 被引量:1
  • 2张宏.IgA肾病的分子遗传学研究[J].中华肾脏病杂志,2005,21(11):641-644. 被引量:12
  • 3Barratt J,Feehally J.IgA nephropathy.J Am Soc Nephrol 2005;16(7):2088-2097
  • 4Tomino Y.IgA nephropathy.Nippon Rinsho 2005; 63 Suppl 5:516-520
  • 5Coppo R,Amore A.Aberrant glycosylation in IgA nephropathy (IgAN).Kidney Int 2004;65(5):1544-1547
  • 6Qin W,Zhou Q,Yang LC,et al.Peripheral blymphocytebeta1,3-galactosyltransferase and chaperone expression in immunoglobulin a nephropathy.J Intern Med 2005;258(5):467-477
  • 7Ju T,Cummings RD.A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.Proc Natl Acad Sci U S A 2002;99(26):16613-16618
  • 8Basta-Jovanovic G.IgA nephropathy.Srp Arh Celok Lek 2004;132(1-2):41-43
  • 9Cherpillod A,Moll S,Venetz JP,et al.IgA nephropathy:what you have need to know in 2005.Rev Med Suisse 2005;1(8):551-554,556
  • 10Renfrow MB,Cooper H J,Tomana M,et al.Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.J Biol Chem 2005;280(19):19136-19145

共引文献7

同被引文献52

  • 1Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3- galactosyhransferase. Proc Natl Acad Sci U S A, 2002,99:16613- 16618.
  • 2Ju T, Aryal RP, Stowell CJ, et al. Regulation of protein O- glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosme. J Cell Bio1,2008,182:531-542.
  • 3Aryal RP, Ju T, Cummings RD. The endoplasmic reticulum chaperone Cosme directly promotes in vitro folding of T-synthase. J Biol Chem, 2010 ,285:2456-2462.
  • 4Ju T, Zheng Q, Cummings ltD. Identification of core 10- glycanT-synthase from Caenorhabditis elegans. Glyeobiology,2006, 16:947-958.
  • 5Wang Y, Ju T, Ding X, et al. Cosmc is an essential chaperone for correct protein O-glycosylation. Proe Natl Aead Sci U S A, 2010, 107:9228-9233.
  • 6Narimatsu Y, Ikehara Y, Iwasaki H, et al. Immunoeytoehemical analysis for intraeellular dynamics of CIGalT associated with molecular chaperone, Cosmc. Bioehem Biophys Res Commun, 2008.366: 199-205.
  • 7Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature, 2005, 437:1252.
  • 8Crew VK, Singleton BK, Green C, et al. New mutations in C1GALT1C1 in individuals with Tn positive phenotype. Br J Haemato1,2008,142:657-667.
  • 9Schietinger A, Philip M, Yoshida BA, et al. A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science, 2006,314 : 304-308.
  • 10Ju T, Lanneau GS, Gautam T, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in cosmc. Cancer Res, 2008 , 68 : 1636-1646.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部